SPM Corp operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares SPM Corp with three other
drug stores in Asia:
New Ray Medicine International Holding Ltd
of Hong Kong
sales of 235.25 million Hong Kong Dollars [US$29.97 million]
of which 97%
was Injection drugs),
Mustika Ratu Tbk PT
(344.68 billion Indonesian Rupiahs [US$24.51 million]
Hin Sang Group (International) Holding Co Ltd
based in Hong Kong
(201.82 million Hong Kong Dollars [US$25.71 million]
of which 89%
was Product Development Segment).
SPM Corp reported sales of 636.02 billion Dong (US$27.41 million)
December of 2017.
increase of 38.0%
versus 2016, when the company's sales were 460.76 billion Dong.
Sales of Real Estate saw an increase
that was more than double the company's growth rate: sales were up
15,755.2% in 2017, from
1.75 billion Dong to 276.75 billion Dong.
Not all segments of SPM Corp experienced an increase in sales in 2017:
sales of Pharmacy Trading fell 51.1% to 117.76 billion Dong.